According to latest Research, the global market for Biological Hemostatic Material should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Biological Hemostatic Material market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Biological Hemostatic Material market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

By segment, Hospital grew percent to account for percent of the total market sales, and Clinic grew percent.

Biological hemostatic agents are active agents that work to provide hemostasis by activating clotting factors in the final stages of the coagulation cascade. Thrombin is activated by calcium and as noted previously acts to convert fibrinogen to fibrin, stabilizing the clot.

This report studies and analyses global Biological Hemostatic Material status and future trends, helps the client to determine the Biological Hemostatic Material market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Biological Hemostatic Material, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights

(1) Global Biological Hemostatic Material market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)

(2) Global Biological Hemostatic Material sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)

(3) China Biological Hemostatic Material sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)

(4) Global Biological Hemostatic Material key consuming regions, consumption quantity, consumption value and demand structure

(5) Global Biological Hemostatic Material key producing regions, capacity, production, and year over year growth

(6) Biological Hemostatic Material industry chains, upstream, midstream and downstream

Market segment by players, this report covers

Johnson & Johnson

BD

Baxter

B.Braun

Cura Medical

GELITA MEDICAL

Curasan AG

Meril Life Sciences

Zhonghui Shengxi

Beijing Datsing Bio-tech

Guizhou Jin Jiu Biotech

Beijing Taikesiman

Foryou Medical

Saikesaisi Holdings Group

Biotemed

Hangzhou Singclean Medical Products

Market segment by Type, covers

Collagen

Gelatin

Polysaccharides

Other

Market segment by Application, can be divided into

Hospital

Clinic

Other

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Report Includes:

Chapter 1: to describe Biological Hemostatic Material product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.

Chapter 2: Global Biological Hemostatic Material market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023

Chapter 3: China Biological Hemostatic Material market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023

Chapter 4: Global key producing regions of Biological Hemostatic Material, percent & CAGR, 2018-2029

Chapter 5: Biological Hemostatic Material industry chain, upstream, medium-stream, and downstream.

Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029

Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029

Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029

Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029

Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.

Chapter 11: Conclusions

1 Market Overview

1.1 Biological Hemostatic Material Definition

1.2 Global Biological Hemostatic Material Market Size and Forecast

1.2.1 By Consumption Value, Global Biological Hemostatic Material Market Size，2018-2029

1.2.2 By Sales Quantity, Global Biological Hemostatic Material Market Size，2018-2029

1.2.3 Global Biological Hemostatic Material Average Selling Price (ASP)，2018-2029

1.3 China Biological Hemostatic Material Market Size and Forecast

1.3.1 By Consumption Value, China Biological Hemostatic Material Market Size，2018-2029

1.3.2 By Sales Quantity, China Biological Hemostatic Material Market Size，2018-2029

1.3.3 China Biological Hemostatic Material Average Selling Price (ASP)， 2018-2029

1.4 Share of China Biological Hemostatic Material Market with Respect to the Global Market

1.4.1 By Consumption Value, China Biological Hemostatic Material Market Share in Global, 2018-2029

1.4.2 By Sales Quantity, China Biological Hemostatic Material Market Share in Global, 2018-2029

1.4.3 Biological Hemostatic Material Market Size: China VS Global, 2018-2029

1.5 Biological Hemostatic Material Market Dynamics

1.5.1 Biological Hemostatic Material Market Drivers

1.5.2 Biological Hemostatic Material Market Restraints

1.5.3 Biological Hemostatic Material Industry Trends

1.5.4 Biological Hemostatic Material Industry Policy

2 Global Leading Manufacturers and Market Share

2.1 By Revenue of Biological Hemostatic Material, Global Market Share by Company, 2018-2023

2.2 By Sales Quantity of Biological Hemostatic Material, Global Market Share by Company, 2018-2023

2.3 Biological Hemostatic Material Average Selling Price (ASP) by Company, 2018-2023

2.4 Global Biological Hemostatic Material Participants, Market Position (Tier 1, Tier 2, and Tier 3)

2.5 Global Biological Hemostatic Material Concentration Ratio

2.6 Global Biological Hemostatic Material Mergers & Acquisitions, Expansion Plans

2.7 Global Biological Hemostatic Material Manufacturers Product Type

2.8 Head Office and Biological Hemostatic Material Production Site of Key Manufacturer

2.9 Biological Hemostatic Material Capacity of Major Manufacturers and Future Plan

3 China Leading Manufacturers and Market Share

3.1 By Revenue of Biological Hemostatic Material, China Market Share by Company, 2018-2023

3.2 By Sales Quantity of Biological Hemostatic Material, China Market Share by Company, 2018-2023

3.3 China Biological Hemostatic Material Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Global Producing Regions

4.1 Global Biological Hemostatic Material Capacity, Output and Capacity Utilization, 2018-2029

4.2 Global Biological Hemostatic Material Capacity by Region

4.3 Global Biological Hemostatic Material Production & Forecast by Region, 2018 VS 2022 VS 2029

4.4 Global Biological Hemostatic Material Production by Region, 2018-2029

4.5 Global Biological Hemostatic Material Production Market Share & Forecast by Region, 2018-2029

5 Industry Chain Analysis

5.1 Biological Hemostatic Material Industry Chain

5.2 Biological Hemostatic Material Upstream Analysis

5.2.1 Biological Hemostatic Material Core Raw Materials

5.2.2 Main Manufacturers of Biological Hemostatic Material Core Raw Materials

5.3 Midstream Analysis

5.4 Downstream Analysis

5.5 Biological Hemostatic Material Production Mode

5.6 Biological Hemostatic Material Procurement Model

5.7 Biological Hemostatic Material Industry Sales Model and Sales Channels

5.7.1 Biological Hemostatic Material Sales Model

5.7.2 Biological Hemostatic Material Typical Distributors

6 Sights by Type

6.1 Biological Hemostatic Material Classification

6.1.1 Collagen

6.1.2 Gelatin

6.1.3 Polysaccharides

6.1.4 Other

6.2 By Type, Global Biological Hemostatic Material Consumption Value & CAGR, 2018 VS 2022 VS 2029

6.3 By Type, Global Biological Hemostatic Material Consumption Value, 2018-2029

6.4 By Type, Global Biological Hemostatic Material Sales Quantity, 2018-2029

6.5 By Type, Global Biological Hemostatic Material Average Selling Price (ASP), 2018-2029

7 Sights by Application

7.1 Biological Hemostatic Material Segment by Application

7.1.1 Hospital

7.1.2 Clinic

7.1.3 Other

7.2 By Application, Global Biological Hemostatic Material Consumption Value & CAGR, 2018 VS 2022 VS 2029

7.3 By Application, Global Biological Hemostatic Material Consumption Value, 2018-2029

7.4 By Application, Global Biological Hemostatic Material Sales Quantity, 2018-2029

7.5 By Application, Global Biological Hemostatic Material Price, 2018-2029

8 Sales Sights by Region

8.1 By Region, Global Biological Hemostatic Material Consumption Value, 2018 VS 2022 VS 2029

8.2 By Region, Global Biological Hemostatic Material Consumption Value, 2018-2029

8.3 By Region, Global Biological Hemostatic Material Sales Quantity, 2018-2029

8.4 North America

8.4.1 North America Biological Hemostatic Material & Forecasts, 2018-2029

8.4.2 By Country, North America Biological Hemostatic Material Market Size Market Share

8.5 Europe

8.5.1 Europe Biological Hemostatic Material Market Size & Forecasts, 2018-2029

8.5.2 By Country, Europe Biological Hemostatic Material Market Size Market Share

8.6 Asia Pacific

8.6.1 Asia Pacific Biological Hemostatic Material Market Size & Forecasts, 2018-2029

8.6.2 By Country/Region, Asia Pacific Biological Hemostatic Material Market Size Market Share

8.7 South America

8.7.1 South America Biological Hemostatic Material Market Size & Forecasts, 2018-2029

8.7.2 By Country, South America Biological Hemostatic Material Market Size Market Share

8.8 Middle East & Africa

9 Sales Sights by Country Level

9.1 By Country, Global Biological Hemostatic Material Market Size & CAGR, 2018 VS 2022 VS 2029

9.2 By Country, Global Biological Hemostatic Material Consumption Value, 2018-2029

9.3 By Country, Global Biological Hemostatic Material Sales Quantity, 2018-2029

9.4 U.S.

9.4.1 U.S. Biological Hemostatic Material Market Size, 2018-2029

9.4.2 By Type, U.S. Biological Hemostatic Material Sales Quantity Market Share, 2022 VS 2029

9.4.3 By Application, U.S. Biological Hemostatic Material Sales Quantity Market Share, 2022 VS 2029

9.5 Europe

9.5.1 Europe Biological Hemostatic Material Market Size, 2018-2029

9.5.2 By Type, Europe Biological Hemostatic Material Sales Quantity Market Share, 2022 VS 2029

9.5.3 By Application, Europe Biological Hemostatic Material Sales Quantity Market Share, 2022 VS 2029

9.6 China

9.6.1 China Biological Hemostatic Material Market Size, 2018-2029

9.6.2 By Type, China Biological Hemostatic Material Sales Quantity Market Share, 2022 VS 2029

9.6.3 By Application, China Biological Hemostatic Material Sales Quantity Market Share, 2022 VS 2029

9.7 Japan

9.7.1 Japan Biological Hemostatic Material Market Size, 2018-2029

9.7.2 By Type, Japan Biological Hemostatic Material Sales Quantity Market Share, 2022 VS 2029

9.7.3 By Application, Japan Biological Hemostatic Material Sales Quantity Market Share, 2022 VS 2029

9.8 South Korea

9.8.1 South Korea Biological Hemostatic Material Market Size, 2018-2029

9.8.2 By Type, South Korea Biological Hemostatic Material Sales Quantity Market Share, 2022 VS 2029

9.8.3 By Application, South Korea Biological Hemostatic Material Sales Quantity Market Share, 2022 VS 2029

9.9 Southeast Asia

9.9.1 Southeast Asia Biological Hemostatic Material Market Size, 2018-2029

9.9.2 By Type, Southeast Asia Biological Hemostatic Material Sales Quantity Market Share, 2022 VS 2029

9.9.3 By Application, Southeast Asia Biological Hemostatic Material Sales Quantity Market Share, 2022 VS 2029

9.10 India

9.10.1 India Biological Hemostatic Material Market Size, 2018-2029

9.10.2 By Type, India Biological Hemostatic Material Sales Quantity Market Share, 2022 VS 2029

9.10.3 By Application, India Biological Hemostatic Material Sales Quantity Market Share, 2022 VS 2029

9.11 Middle East & Africa

9.11.1 Middle East & Africa Biological Hemostatic Material Market Size, 2018-2029

9.11.2 By Type, Middle East & Africa Biological Hemostatic Material Sales Quantity Market Share, 2022 VS 2029

9.11.3 By Application, Middle East & Africa Biological Hemostatic Material Sales Quantity Market Share, 2022 VS 2029

10 Manufacturers Profile

10.1 Johnson & Johnson

10.1.1 Johnson & Johnson Company Information, Head Office, Market Area, and Industry Position

10.1.2 Johnson & Johnson Biological Hemostatic Material Models, Specifications, and Application

10.1.3 Johnson & Johnson Biological Hemostatic Material Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.1.4 Johnson & Johnson Company Profile and Main Business

10.1.5 Johnson & Johnson Recent Developments

10.2 BD

10.2.1 BD Company Information, Head Office, Market Area, and Industry Position

10.2.2 BD Biological Hemostatic Material Models, Specifications, and Application

10.2.3 BD Biological Hemostatic Material Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.2.4 BD Company Profile and Main Business

10.2.5 BD Recent Developments

10.3 Baxter

10.3.1 Baxter Company Information, Head Office, Market Area, and Industry Position

10.3.2 Baxter Biological Hemostatic Material Models, Specifications, and Application

10.3.3 Baxter Biological Hemostatic Material Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.3.4 Baxter Company Profile and Main Business

10.3.5 Baxter Recent Developments

10.4 B.Braun

10.4.1 B.Braun Company Information, Head Office, Market Area, and Industry Position

10.4.2 B.Braun Biological Hemostatic Material Models, Specifications, and Application

10.4.3 B.Braun Biological Hemostatic Material Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.4.4 B.Braun Company Profile and Main Business

10.4.5 B.Braun Recent Developments

10.5 Cura Medical

10.5.1 Cura Medical Company Information, Head Office, Market Area, and Industry Position

10.5.2 Cura Medical Biological Hemostatic Material Models, Specifications, and Application

10.5.3 Cura Medical Biological Hemostatic Material Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.5.4 Cura Medical Company Profile and Main Business

10.5.5 Cura Medical Recent Developments

10.6 GELITA MEDICAL

10.6.1 GELITA MEDICAL Company Information, Head Office, Market Area, and Industry Position

10.6.2 GELITA MEDICAL Biological Hemostatic Material Models, Specifications, and Application

10.6.3 GELITA MEDICAL Biological Hemostatic Material Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.6.4 GELITA MEDICAL Company Profile and Main Business

10.6.5 GELITA MEDICAL Recent Developments

10.7 Curasan AG

10.7.1 Curasan AG Company Information, Head Office, Market Area, and Industry Position

10.7.2 Curasan AG Biological Hemostatic Material Models, Specifications, and Application

10.7.3 Curasan AG Biological Hemostatic Material Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.7.4 Curasan AG Company Profile and Main Business

10.7.5 Curasan AG Recent Developments

10.8 Meril Life Sciences

10.8.1 Meril Life Sciences Company Information, Head Office, Market Area, and Industry Position

10.8.2 Meril Life Sciences Biological Hemostatic Material Models, Specifications, and Application

10.8.3 Meril Life Sciences Biological Hemostatic Material Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.8.4 Meril Life Sciences Company Profile and Main Business

10.8.5 Meril Life Sciences Recent Developments

10.9 Zhonghui Shengxi

10.9.1 Zhonghui Shengxi Company Information, Head Office, Market Area, and Industry Position

10.9.2 Zhonghui Shengxi Biological Hemostatic Material Models, Specifications, and Application

10.9.3 Zhonghui Shengxi Biological Hemostatic Material Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.9.4 Zhonghui Shengxi Company Profile and Main Business

10.9.5 Zhonghui Shengxi Recent Developments

10.10 Beijing Datsing Bio-tech

10.10.1 Beijing Datsing Bio-tech Company Information, Head Office, Market Area, and Industry Position

10.10.2 Beijing Datsing Bio-tech Biological Hemostatic Material Models, Specifications, and Application

10.10.3 Beijing Datsing Bio-tech Biological Hemostatic Material Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.10.4 Beijing Datsing Bio-tech Company Profile and Main Business

10.10.5 Beijing Datsing Bio-tech Recent Developments

10.11 Guizhou Jin Jiu Biotech

10.11.1 Guizhou Jin Jiu Biotech Company Information, Head Office, Market Area, and Industry Position

10.11.2 Guizhou Jin Jiu Biotech Biological Hemostatic Material Models, Specifications, and Application

10.11.3 Guizhou Jin Jiu Biotech Biological Hemostatic Material Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.11.4 Guizhou Jin Jiu Biotech Company Profile and Main Business

10.11.5 Guizhou Jin Jiu Biotech Recent Developments

10.12 Beijing Taikesiman

10.12.1 Beijing Taikesiman Company Information, Head Office, Market Area, and Industry Position

10.12.2 Beijing Taikesiman Biological Hemostatic Material Models, Specifications, and Application

10.12.3 Beijing Taikesiman Biological Hemostatic Material Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.12.4 Beijing Taikesiman Company Profile and Main Business

10.12.5 Beijing Taikesiman Recent Developments

10.13 Foryou Medical

10.13.1 Foryou Medical Company Information, Head Office, Market Area, and Industry Position

10.13.2 Foryou Medical Biological Hemostatic Material Models, Specifications, and Application

10.13.3 Foryou Medical Biological Hemostatic Material Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.13.4 Foryou Medical Company Profile and Main Business

10.13.5 Foryou Medical Recent Developments

10.14 Saikesaisi Holdings Group

10.14.1 Saikesaisi Holdings Group Company Information, Head Office, Market Area, and Industry Position

10.14.2 Saikesaisi Holdings Group Biological Hemostatic Material Models, Specifications, and Application

10.14.3 Saikesaisi Holdings Group Biological Hemostatic Material Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.14.4 Saikesaisi Holdings Group Company Profile and Main Business

10.14.5 Saikesaisi Holdings Group Recent Developments

10.15 Biotemed

10.15.1 Biotemed Company Information, Head Office, Market Area, and Industry Position

10.15.2 Biotemed Biological Hemostatic Material Models, Specifications, and Application

10.15.3 Biotemed Biological Hemostatic Material Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.15.4 Biotemed Company Profile and Main Business

10.15.5 Biotemed Recent Developments

10.16 Hangzhou Singclean Medical Products

10.16.1 Hangzhou Singclean Medical Products Company Information, Head Office, Market Area, and Industry Position

10.16.2 Hangzhou Singclean Medical Products Biological Hemostatic Material Models, Specifications, and Application

10.16.3 Hangzhou Singclean Medical Products Biological Hemostatic Material Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.16.4 Hangzhou Singclean Medical Products Company Profile and Main Business

10.16.5 Hangzhou Singclean Medical Products Recent Developments

11 Conclusion

12 Appendix

12.1 Research Methodology

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Market Estimation Model

12.4 Disclaimer

Table 1. Biological Hemostatic Material Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million

Table 2. Biological Hemostatic Material Market Restraints

Table 3. Biological Hemostatic Material Market Trends

Table 4. Biological Hemostatic Material Industry Policy

Table 5. Global Biological Hemostatic Material Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022

Table 6. Global Biological Hemostatic Material Revenue Share by Company, 2018-2023, Ranked by Data of 2022

Table 7. Global Biological Hemostatic Material Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022

Table 8. Global Biological Hemostatic Material Sales Quantity by Company, 2018-2023, Ranked by Data of 2022

Table 9. Global Biological Hemostatic Material Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)

Table 10. Global Biological Hemostatic Material Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Biological Hemostatic Material Mergers & Acquisitions, Expansion Plans

Table 12. Global Biological Hemostatic Material Manufacturers Product Type

Table 13. Head Office and Biological Hemostatic Material Production Site of Key Manufacturer

Table 14. Biological Hemostatic Material Capacity of Major Manufacturers and Future Plan

Table 15. China Biological Hemostatic Material Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022

Table 16. China Biological Hemostatic Material Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022

Table 17. China Biological Hemostatic Material Sales Quantity by Company, 2018-2023, Ranked by Data of 2022

Table 18. Global Biological Hemostatic Material Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)

Table 19. Global Biological Hemostatic Material Production by Region, 2018-2023, (K Units)

Table 20. Global Biological Hemostatic Material Production Forecast by Region, 2024-2029, (K Units)

Table 21. Global Key Players of Biological Hemostatic Material Upstream (Raw Materials)

Table 22. Global Biological Hemostatic Material Typical Customers

Table 23. Biological Hemostatic Material Typical Distributors

Table 24. By Type, Global Biological Hemostatic Material Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 25. By Application, Global Biological Hemostatic Material Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 26. By Region, Global Biological Hemostatic Material Consumption Value, 2018 VS 2022 VS 2029, US$ Million

Table 27. By Region, Global Biological Hemostatic Material Consumption Value, 2018-2029, US$ Million

Table 28. By Region, Global Biological Hemostatic Material Sales Quantity, 2018-2029, (K Units)

Table 29. By Country, Global Biological Hemostatic Material Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 30. By Country, Global Biological Hemostatic Material Consumption Value, 2018-2029, US$ Million

Table 31. By Country, Global Biological Hemostatic Material Consumption Value Market Share, 2018-2029

Table 32. By Country, Global Biological Hemostatic Material Sales Quantity, 2018-2029, (K Units)

Table 33. By Country, Global Biological Hemostatic Material Sales Quantity Market Share, 2018-2029

Table 34. Johnson & Johnson Company Information, Head Office, Market Area, and Industry Position

Table 35. Johnson & Johnson Biological Hemostatic Material Models, Specifications, and Application

Table 36. Johnson & Johnson Biological Hemostatic Material Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 37. Johnson & Johnson Company Profile and Main Business

Table 38. Johnson & Johnson Recent Developments

Table 39. BD Company Information, Head Office, Market Area, and Industry Position

Table 40. BD Biological Hemostatic Material Models, Specifications, and Application

Table 41. BD Biological Hemostatic Material Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 42. BD Company Profile and Main Business

Table 43. BD Recent Developments

Table 44. Baxter Company Information, Head Office, Market Area, and Industry Position

Table 45. Baxter Biological Hemostatic Material Models, Specifications, and Application

Table 46. Baxter Biological Hemostatic Material Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 47. Baxter Company Profile and Main Business

Table 48. Baxter Recent Developments

Table 49. B.Braun Company Information, Head Office, Market Area, and Industry Position

Table 50. B.Braun Biological Hemostatic Material Models, Specifications, and Application

Table 51. B.Braun Biological Hemostatic Material Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 52. B.Braun Company Profile and Main Business

Table 53. B.Braun Recent Developments

Table 54. Cura Medical Company Information, Head Office, Market Area, and Industry Position

Table 55. Cura Medical Biological Hemostatic Material Models, Specifications, and Application

Table 56. Cura Medical Biological Hemostatic Material Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 57. Cura Medical Company Profile and Main Business

Table 58. Cura Medical Recent Developments

Table 59. GELITA MEDICAL Company Information, Head Office, Market Area, and Industry Position

Table 60. GELITA MEDICAL Biological Hemostatic Material Models, Specifications, and Application

Table 61. GELITA MEDICAL Biological Hemostatic Material Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 62. GELITA MEDICAL Company Profile and Main Business

Table 63. GELITA MEDICAL Recent Developments

Table 64. Curasan AG Company Information, Head Office, Market Area, and Industry Position

Table 65. Curasan AG Biological Hemostatic Material Models, Specifications, and Application

Table 66. Curasan AG Biological Hemostatic Material Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 67. Curasan AG Company Profile and Main Business

Table 68. Curasan AG Recent Developments

Table 69. Meril Life Sciences Company Information, Head Office, Market Area, and Industry Position

Table 70. Meril Life Sciences Biological Hemostatic Material Models, Specifications, and Application

Table 71. Meril Life Sciences Biological Hemostatic Material Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 72. Meril Life Sciences Company Profile and Main Business

Table 73. Meril Life Sciences Recent Developments

Table 74. Zhonghui Shengxi Company Information, Head Office, Market Area, and Industry Position

Table 75. Zhonghui Shengxi Biological Hemostatic Material Models, Specifications, and Application

Table 76. Zhonghui Shengxi Biological Hemostatic Material Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 77. Zhonghui Shengxi Company Profile and Main Business

Table 78. Zhonghui Shengxi Recent Developments

Table 79. Beijing Datsing Bio-tech Company Information, Head Office, Market Area, and Industry Position

Table 80. Beijing Datsing Bio-tech Biological Hemostatic Material Models, Specifications, and Application

Table 81. Beijing Datsing Bio-tech Biological Hemostatic Material Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 82. Beijing Datsing Bio-tech Company Profile and Main Business

Table 83. Beijing Datsing Bio-tech Recent Developments

Table 84. Guizhou Jin Jiu Biotech Company Information, Head Office, Market Area, and Industry Position

Table 85. Guizhou Jin Jiu Biotech Biological Hemostatic Material Models, Specifications, and Application

Table 86. Guizhou Jin Jiu Biotech Biological Hemostatic Material Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 87. Guizhou Jin Jiu Biotech Company Profile and Main Business

Table 88. Guizhou Jin Jiu Biotech Recent Developments

Table 89. Beijing Taikesiman Company Information, Head Office, Market Area, and Industry Position

Table 90. Beijing Taikesiman Biological Hemostatic Material Models, Specifications, and Application

Table 91. Beijing Taikesiman Biological Hemostatic Material Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 92. Beijing Taikesiman Company Profile and Main Business

Table 93. Beijing Taikesiman Recent Developments

Table 94. Foryou Medical Company Information, Head Office, Market Area, and Industry Position

Table 95. Foryou Medical Biological Hemostatic Material Models, Specifications, and Application

Table 96. Foryou Medical Biological Hemostatic Material Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 97. Foryou Medical Company Profile and Main Business

Table 98. Foryou Medical Recent Developments

Table 99. Saikesaisi Holdings Group Company Information, Head Office, Market Area, and Industry Position

Table 100. Saikesaisi Holdings Group Biological Hemostatic Material Models, Specifications, and Application

Table 101. Saikesaisi Holdings Group Biological Hemostatic Material Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 102. Saikesaisi Holdings Group Company Profile and Main Business

Table 103. Saikesaisi Holdings Group Recent Developments

Table 104. Biotemed Company Information, Head Office, Market Area, and Industry Position

Table 105. Biotemed Biological Hemostatic Material Models, Specifications, and Application

Table 106. Biotemed Biological Hemostatic Material Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 107. Biotemed Company Profile and Main Business

Table 108. Biotemed Recent Developments

Table 109. Hangzhou Singclean Medical Products Company Information, Head Office, Market Area, and Industry Position

Table 110. Hangzhou Singclean Medical Products Biological Hemostatic Material Models, Specifications, and Application

Table 111. Hangzhou Singclean Medical Products Biological Hemostatic Material Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 112. Hangzhou Singclean Medical Products Company Profile and Main Business

Table 113. Hangzhou Singclean Medical Products Recent Developments

List of Figures

Figure 1. Biological Hemostatic Material Picture

Figure 2. Global Biological Hemostatic Material Consumption Value, (US$ million) & (2018-2029)

Figure 3. Global Biological Hemostatic Material Sales Quantity, (K Units) & (2018-2029)

Figure 4. Global Biological Hemostatic Material Average Selling Price (ASP), (2018-2029) & (US$/Unit)

Figure 5. China Biological Hemostatic Material Consumption Value, (US$ million) & (2018-2029)

Figure 6. China Biological Hemostatic Material Sales Quantity (K Units) & (2018-2029)

Figure 7. China Biological Hemostatic Material Average Selling Price (ASP), (US$/Unit) & (2018-2029)

Figure 8. By Consumption Value, China Biological Hemostatic Material Market Share of Global, 2018-2029

Figure 9. By Sales Quantity, China Biological Hemostatic Material Market Share of Global, 2018-2029

Figure 10. Global Biological Hemostatic Material Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022

Figure 11. China Biological Hemostatic Material Key Participants, Market Share, 2022

Figure 12. Global Biological Hemostatic Material Capacity, Production and Capacity Utilization, 2018-2029

Figure 13. Global Biological Hemostatic Material Capacity Market Share by Region, 2022 VS 2029

Figure 14. Global Biological Hemostatic Material Production Market Share & Forecast by Region, 2018-2029

Figure 15. Biological Hemostatic Material Industry Chain

Figure 16. Biological Hemostatic Material Procurement Model

Figure 17. Biological Hemostatic Material Sales Model

Figure 18. Biological Hemostatic Material Sales Channels, Direct Sales, and Distribution

Figure 19. Collagen

Figure 20. Gelatin

Figure 21. Polysaccharides

Figure 22. Other

Figure 23. By Type, Global Biological Hemostatic Material Consumption Value, 2018-2029, US$ Million

Figure 24. By Type, Global Biological Hemostatic Material Consumption Value Market Share, 2018-2029

Figure 25. By Type, Global Biological Hemostatic Material Sales Quantity, 2018-2029, (K Units)

Figure 26. By Type, Global Biological Hemostatic Material Sales Quantity Market Share, 2018-2029

Figure 27. By Type, Global Biological Hemostatic Material Average Selling Price (ASP), 2018-2029, (US$/Unit)

Figure 28. Hospital

Figure 29. Clinic

Figure 30. Other

Figure 31. By Application, Global Biological Hemostatic Material Consumption Value, 2018-2029, US$ Million

Figure 32. By Application, Global Biological Hemostatic Material Consumption Value Market Share, 2018-2029

Figure 33. By Application, Global Biological Hemostatic Material Sales Quantity, 2018-2029, (K

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)